Dr. Michael Bublik, MD

Dr. Bublik practices at Central Surgery Center of Glendale in Glendale, California.

Dr. Bublik's NPI, 1679784664, was assigned on May 24, 2007. Dr. Bublik graduated from Keck School of Medicine of USC in 2005. Dr. Bublik holds California license A112615.

Dr. Bublik's primary practice is Central Surgery Center of Glendale, at 800 S Central Ave, Glendale, CA 91204 in Los Angeles County. The practice phone is (626) 484-0606.

Dr. Bublik's primary practice is Central Surgery Center of Glendale in Glendale, California. Dr. Bublik is also affiliated with Adventist Health Glendale. The medical group on file is Southern California ENT and Allergy Associates. Dmand AI also links Dr. Bublik to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bublik practices, 4 sites in all. Vendor and product names are available with a free account.

Facial plastic surgery is Dr. Bublik's primary specialty in the NPI Registry, under taxonomy code 207YS0123X. Dr. Bublik is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Bublik's licenses on file in 2 states: California and Florida.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Bublik treats.

CMS data shows 21,463 Medicare services from Dr. Bublik across 30 procedure codes in 2024, for 1,574 Medicare patients. Medicare paid $1,080,738 for them.

CMS counts 1,574 Medicare patients who saw Dr. Bublik in 2024. The largest group is 65 to 74, with 762 patients. 75% of them have arthritis, and 75% have high blood pressure. 74% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bublik's median patient age at 64, with 54% women.

In 2024, Dr. Bublik wrote 6,734 Medicare Part D claims for 1,142 patients. 99% of them were for generic drugs. CMS names the drug for 6,568 of them, across 34 drugs with 11 or more claims each, at $91,435 in total drug cost. In 2023, CMS named 4,682 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bublik for performance year 2024, reported individually. Dr. Bublik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bublik as offering telehealth.

Dmand AI links 9 papers to Dr. Bublik, published from 2006 to 2013. 2012 was the busiest year, with 3. The most frequent topics are Endoscopy, Epistaxis and Esthetics. Dr. Bublik has published most often in Facial Plast Surg. Dr. Bublik's most frequent co-authors are Roy R. Casiano, MD, Richard Davis, FACS, MD and Zoukaa B. Sargi, MD.

CMS Open Payments shows 213 general payments to Dr. Bublik from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Intersect ENT, Inc. paid the most, $2,712.

Dmand AI lists 1 award for Dr. Bublik.

Dr. Bublik graduated from Keck School of Medicine of USC in 2005. Dr. Bublik is a member of NHS.

Dr. Bublik is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.